News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

MicroRNA Convicted Of Triggering Metastasis_2319

Started by 0375be77, January 24, 2011, 08:36:51 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

0375be77

"I was able to fully reverse microRNA-10b induced migration and invasion, suggesting that HoxD10 is indeed a functional target," Ma explains.
MicroRNA Convicted Of Triggering Metastasis
            
            
Labs have been probing the relationship between aberrant microRNA levels and cancer for several years. They've shown that some microRNAs cause normal cells to divide rapidly and form tumors, but they've never demonstrated that microRNAs subsequently cause cancer cells to metastasize.
To test whether she had removed the brakes during her experiment, awakening the dormant migration process, Ma boosted the level of HoxD10 in the cancer cells with artificially high levels of microRNA-10b. The cells lost their newly acquired abilities to move and invade.
Full Citation:    Nature, online edition,You are not allowed to view links. Register or Login, Sept. 26, 2007    "Tumour invasion and metastasis initiated by microRNA-10b in breast cancer"    Li Ma(1),You are not allowed to view links. Register or Login, Julie Teruya-Feldstein(2) and Robert Weinberg(1)    
This research is funded by the Life Sciences Research Foundation, the National Institutes of Health and the Ludwig Center for Molecular Oncology at MIT.
(1)   Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA
Next, Ma forced non-metastatic human breast cancer cells to produce lots of microRNA-10b by inserting extra copies of the gene. She injected the altered cancer cells into the mammary fat pads of mice, which soon developed breast tumors that metastasized.
Ma began with a list of 29 microRNAs expressed at different levels in tumors versus normal tissue. She examined their production in two groups of cancer cells--metastatic and non-metastatic. Metastatic cancer cells (including those taken directly from patients) contained much higher levels of one microRNA called microRNA-10b.
So what caused this stunning metamorphosis?
MicroRNAs typically disrupt protein production by binding to the messenger RNAs that copy DNA instructions for proteins and carry them to "translators." Ma used a program developed in the lab of Whitehead Member David Bartel to search for the target of microRNA-10b. She identified several candidates, including the messenger RNA for a gene called HoxD10.
"During normal development, this microRNA probably enables cells to move from one part of the embryo to another," adds Weinberg. "Its original function has been co-opted by carcinoma cells."
Now, working in the lab of Whitehead Member Robert Weinberg, postdoctoral fellow Li Ma has coaxed cancer cells to break away from a tumor and colonize distant tissues in mice by simply increasing the level of one microRNA. Her results appear online in Nature on September 26.
"Li has shown that a specific microRNA is able to cause profound changes in the behavior of cancer cells, which is striking considering that 10 years ago no one suspected microRNAs were involved in any biological process,You are not allowed to view links. Register or Login," says Weinberg, who is also an MIT professor of biology.
Generally involved in development, Hox proteins control many genes active in an embryo. Some Hox proteins have also been implicated in cancer. HoxD10, for example,You are not allowed to view links. Register or Login, can block the expression of genes required for cancer cells to move--essentially applying the brakes to a migration process.
Robert Weinberg's primary affiliation is with Whitehead Institute for Biomedical Research, where his laboratory is located and all his research is conducted. He is also a professor of biology at Massachusetts Institute of Technology.
(2)   Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY

 

Quick Reply

Name:
Email:
Verification:
Please leave this box empty:
Type the letters shown in the picture
Listen to the letters / Request another image

Type the letters shown in the picture:
To verify you are not a bot, how much is 1 + 4 ?:
To verify you are not a bot, how much is two plus two?:
Shortcuts: ALT+S post or ALT+P preview